Cargando…
Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors
BACKGROUND: Triple-negative breast cancer (TNBC) is a rare and aggressive breast cancer subtype. Unlike the estrogen receptor-positive subtype, whose recurrence risk can be predicted by gene expression-based signature, TNBC is more heterogeneous, with diverse drug sensitivity levels to standard regi...
Autores principales: | Suntiparpluacha, Monthira, Chanthercrob, Jantappapa, Sa-nguanraksa, Doonyapat, Sitthikornpaiboon, Juthamas, Chaiboonchoe, Amphun, Kueanjinda, Patipark, Jinawath, Natini, Sampattavanich, Somponnat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269579/ https://www.ncbi.nlm.nih.gov/pubmed/37334114 http://dx.doi.org/10.7717/peerj.15350 |
Ejemplares similares
-
Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma
por: Prasopporn, Sunisa, et al.
Publicado: (2022) -
Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma
por: Prasopporn, Sunisa, et al.
Publicado: (2023) -
The KRAS-Mutant Consensus Molecular Subtype 3 Reveals an Immunosuppressive Tumor Microenvironment in Colorectal Cancer
por: Tanjak, Pariyada, et al.
Publicado: (2023) -
Comprehensive drug response profiling and pan-omic analysis identified therapeutic candidates and prognostic biomarkers for Asian cholangiocarcinoma
por: Jamnongsong, Supawan, et al.
Publicado: (2022) -
Novel Analytical Platform For Robust Identification of Cell Migration Inhibitors
por: Somchai, Parinyachat, et al.
Publicado: (2020)